Sinofn Health
SINOFN Health Co., Ltd. is the premier supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and deeply rooted in the rigorous standards of the Chinese Academy of Sciences, we serve as a strategic hub in Shanghai for global brands. We bridge the gap between high-end biotechnology and accessible consumer nutrition, delivering manufacturing excellence for specialized dietary needs and general wellness.
In an era of supply chain volatility, SINOFN provides a stable, vertically integrated manufacturing ecosystem. From raw material sourcing (CAS-verified ingredients) to final packaging, we minimize geopolitical and logistical risks for our partners, ensuring consistency in every batch.
The industry is shifting from generic multivitamins to targeted, personalized solutions. We utilize our R&D capabilities to help brands innovate with bioavailability-enhanced formulas, such as our NMN and peptide-based nutrient delivery systems.
Navigating the complex regulatory landscape of FSMP (Foods for Special Medical Purposes) and global nutraceutical regulations requires expertise. Our compliance team ensures that every formulation meets FDA, EU, and local regional standards for safety and labeling.
Led by Dr. Tan Shengjie (Peking University Medical School), our team specializes in metabolic disorder formulations. With 15+ years of experience, Dr. Tan ensures that our "food as medicine" approach is clinically sound.
Dr. Zhang Ying, Associate Researcher at CAS, leads our R&D department. Her work in bioactive compound delivery systems allows SINOFN to create supplements that are not only potent but highly absorbable.
Hans van Dijk, our Senior Scientist from the Netherlands, brings EU-standard manufacturing precision to our facilities, bridging the gap between Eastern research and Western quality benchmarks.
We are integrating AI predictive models to analyze market trends and ingredient interactions, significantly shortening the product development lifecycle for our clients.
Our "Full-Plant Integration" utilizes blockchain technology to track raw materials from procurement to the consumer’s hand, offering unparalleled transparency and brand protection.
Beyond nutrition, we are scaling sustainable extraction methods for plant-based ingredients (like our Tremella Polysaccharides), ensuring our environmental footprint aligns with the future of "Clean Label" manufacturing.
Through our Tianjin R&D center and strategic partnership with the Chinese Academy of Sciences, we perform pilot-scale prototyping and stability testing to validate every formula before mass production.
Yes. While we serve global enterprises, we offer scalable manufacturing solutions. We are designed to assist brands in their journey from pilot-scale innovation to full-market supply.
With 10+ dedicated GMP lines and an annual capacity exceeding 500 million units, we possess the infrastructure to handle both niche-specialized requirements and high-volume mass production.